From: Pneumonia-targeted lopinavir/ritonavir-based treatment for patients with COVID-19: an early-period retrospective single center observational study
Variables
Odds ratio
95% Confidence interval
P value
Age (1 year increasing)
1.108
(1.021–1.202)
0.014
Cardio-pulmonary diseases (yes vs. no)
0.964
(0.105–8.867)
0.974
Neurological diseases (yes vs. no)
3.421
(0.451–25.935)
0.234